loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2009_107___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    SEQUEL PHARMACHEM PRIVATE LTD. IN 400 706 Nerul

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SEQUEL PHARMACHEM PRIVATE LTD. Nerul IN (1)

    filter

    01 Lamotrigine (1)

    filter

    01 India (1)

    filter

    01 Expired (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    SEQUEL PHARMACHEM PRIVATE LTD. Neru...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Lamotrigine

      PDF Supplier PDF
      URL Supplier Web Content
      R0-CEP 2009-107 - Rev 00
      Expired
      Chemical
      2011-04-11
      2016-04-25
      1756
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2009-107 - Rev 00 of Sequel Pharmachem Private Ltd. Nerul In

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2009-107 - Rev 00 of Sequel Pharmachem Private Ltd. Nerul In 1

      20

      Sequel Pharmachem Private Ltd. Nerul In, based in India, is a pharmaceutical company.

      One of their significant offerings is Lamotrigine, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2009-107 - Rev 00

      This Chemical Type CEP, issued on April 11, 2011, remains in force until April 25, 2016, ensuring its reliability within the pharmaceutical industry.

      Substance Number 1756 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY